Despite its small size, its venom is highly potent, causing significant local and systemic bleeding.
Vasculotoxic snakes belong to the families Viperidae (vipers) and Elapidae (cobras, taipans, and kraits). Some of the most venomous snakes in the world, such as the inland taipan (Oxyuranus microlepidotus) and the eastern cobra (Naja naja), are vasculotoxic.
Vasculotoxic snake bite remains a challenge due to geographic variability in venom composition. For example, Echis carinatus venom is more procoagulant, while Daboia russelii causes more prominent capillary leak. Antivenom efficacy is species-specific; monovalent antivenom is ideal but often unavailable. Delayed administration is the single greatest risk factor for death. Furthermore, the use of antihistamines or steroids before antivenom does not prevent anaphylaxis and is not recommended.
Unlike physiological thrombin, venom serine proteases (e.g., ancrod, batroxobin) cleave fibrinogen to fibrin without activating factor XIII. This produces unstable, loose fibrin clots that are rapidly lysed, leading to defibrination syndrome . Concurrently, venom activates factor X and prothrombin, leading to consumptive coagulopathy.
Future directions include the development of small-molecule inhibitors (e.g., batimastat for SVMPs) and region-specific antivenomics to improve treatment outcomes.